Stocks CART Financial statements
Financial statementsMaplebear Inc. financial statements
Income statement, balance sheet and cash flow statement for the last 5 fiscal years, taken from the XBRL data Maplebear Inc. files with the SEC in its annual reports.
In USD millions, except per-share amounts. Outflows in the cash flow statement are negative.
Income statement
| FY2021 | FY2023 | FY2023 | FY2024 | FY2025 | |
|---|---|---|---|---|---|
| Revenue | 1,834 | 2,551 | 3,042 | 3,378 | 3,742 |
| Cost of revenue | 608 | 720 | 764 | 836 | 984 |
| Gross profit | 1,226 | 1,831 | 2,278 | 2,542 | 2,758 |
| Research and development | 368 | 518 | 2,312 | 604 | 650 |
| Selling and marketing | 394 | 660 | 961 | 808 | 854 |
| General and administrative | 288 | 339 | 803 | 363 | 482 |
| Operating expenses | 1,312 | 1,769 | 4,420 | 2,053 | 2,259 |
| Operating income | -86 | 62 | -2,142 | 489 | 498 |
| Other non-operating income | 12 | -8 | 0 | -3 | 1 |
| Pre-tax income | -72 | 71 | -2,061 | 552 | 556 |
| Income tax | 1 | -357 | -439 | 95 | 109 |
| Net income | -73 | 428 | -1,622 | 457 | 447 |
| EBITDA | -70 | 96 | -2,099 | 545 | 589 |
| EPS, basic | -1.12 | 1.08 | -12.43 | 1.69 | 1.68 |
| EPS, diluted | -1.12 | 0.96 | -12.43 | 1.58 | 1.60 |
| Shares, basic (weighted) | 65.9 | 71.9 | 131 | 265 | 261 |
| Shares, diluted (weighted) | 65.9 | 101 | 131 | 289 | 280 |
Balance sheet
| FY2021 | FY2023 | FY2023 | FY2024 | FY2025 | |
|---|---|---|---|---|---|
| Cash and equivalents | 1,146 | 1,505 | 2,137 | 1,278 | 637 |
| Short-term investments | 209 | 49 | 91 | 50 | |
| Receivables | 842 | 853 | 1,014 | 1,127 | |
| Other current assets | 109 | 129 | 162 | 213 | |
| Total current assets | 2,740 | 3,305 | 2,697 | 2,199 | |
| Property, plant and equipment | 38 | 135 | 200 | 218 | |
| Lease right-of-use assets | 41 | 31 | 21 | 30 | |
| Goodwill | 263 | 317 | 318 | 317 | 393 |
| Intangible assets | 103 | 77 | 52 | 71 | |
| Long-term investments | 28 | 0 | 0 | 81 | |
| Other non-current assets | 12 | 12 | 38 | 14 | |
| Total assets | 3,669 | 4,727 | 4,115 | 3,687 | |
| Accounts payable | 88 | 72 | 80 | 70 | |
| Accrued liabilities | 515 | 451 | 505 | 634 | |
| Deferred revenue | 179 | 197 | 200 | 211 | |
| Total current liabilities | 795 | 733 | 798 | 917 | |
| Lease liabilities | 36 | 27 | 13 | 33 | |
| Other non-current liabilities | 80 | 40 | 25 | 24 | |
| Total liabilities | 911 | 800 | 836 | 974 | |
| Paid-in capital | 918 | 6,382 | 6,687 | 7,005 | |
| Retained earnings | -977 | -2,635 | -3,585 | -4,486 | |
| Other comprehensive income | -5 | 3 | -9 | -1 | |
| Shareholders' equity | -573 | -64 | 3,750 | 3,093 | 2,518 |
| Total equity | -573 | -64 | 3,750 | 3,093 | 2,518 |
| Total liabilities and equity | 3,669 | 4,727 | 4,115 | 3,687 | |
| Shares outstanding | 72.2 | 279 | 261 | 243 |
Cash flow statement
| FY2021 | FY2023 | FY2023 | FY2024 | FY2025 | |
|---|---|---|---|---|---|
| Net income | -73 | 428 | -1,622 | 457 | 447 |
| Depreciation and amortization | 16 | 34 | 43 | 56 | 91 |
| Stock-based compensation | 22 | 33 | 2,756 | 300 | 352 |
| Deferred income tax | -2 | -373 | -459 | 59 | 98 |
| Change in receivables | -318 | -21 | -33 | -185 | -121 |
| Change in payables | 36 | 25 | -16 | 8 | -11 |
| Cash from operations | -204 | 277 | 586 | 687 | 971 |
| Capital expenditures | -13 | -24 | -54 | -64 | -61 |
| Acquisitions | -54 | -93 | 0 | 0 | -106 |
| Purchases of investments | -623 | -158 | -110 | -110 | -280 |
| Sales and maturities of investments | 369 | 394 | 301 | 70 | 243 |
| Cash from investing | -330 | 117 | 135 | -107 | -208 |
| Stock issued | 125 | 0 | 0 | 80 | 8 |
| Share buybacks | 0 | 0 | -36 | -1,402 | -1,386 |
| Cash from financing | 464 | 46 | -30 | -1,413 | -1,391 |
| Exchange rate effect | -1 | -6 | 3 | -11 | 4 |
| Net change in cash | -71 | 434 | 694 | -844 | -623 |
| Free cash flow | -217 | 253 | 532 | 623 | 910 |
| Income taxes paid | 4 | 3 | 54 | 13 | 43 |
Key metrics
Profitability
| Metric | Value | How it is calculated |
|---|---|---|
| Gross margin | 72.6% | Gross profit / revenue. |
| Operating margin | 14.8% | Operating income / revenue. |
| EBITDA margin | 17.6% | EBITDA (operating income + depreciation and amortization) / revenue. |
| Net margin | 12.0% | Net income / revenue. |
| FCF margin | 29.5% | Free cash flow (cash from operations - capital expenditures) / revenue. |
| Operating cash flow margin | 30.9% | Cash from operations / revenue. |
| Return on equity (ROE) | 20.7% | Net income / average shareholders' equity (opening and closing). Not shown when equity is negative. |
| Return on assets (ROA) | 13.7% | Net income / average total assets. |
| Return on invested capital (ROIC) | 29.7% | Approximation: operating income x (1 - tax rate) / average (total debt + equity - cash). Tax rate is the effective rate when between 0% and 50%, else 21%. |
| R&D / revenue | 17.7% | Research and development expense / revenue. |
| Stock-based pay / revenue | 10.1% | Stock-based compensation (from the cash flow statement) / revenue. |
| Capex / revenue | 1.4% | Capital expenditures / revenue. |
| D&A / revenue | 2.8% | Depreciation and amortization / revenue. |
Growth
| Metric | Value | How it is calculated |
|---|---|---|
| Revenue growth, 1y | 10.8% | Revenue vs the same period a year earlier. Only from a positive base. |
| Revenue CAGR, 3y | 13.6% | Compound annual growth of revenue over 3 fiscal years: (end / start)^(1/3) - 1. Only when both values are positive. |
| Gross profit growth, 1y | 8.5% | Gross profit vs the same period a year earlier. Only from a positive base. |
| Gross profit CAGR, 3y | 14.6% | Compound annual growth of gross profit over 3 fiscal years: (end / start)^(1/3) - 1. Only when both values are positive. |
| Operating income growth, 1y | 1.8% | Operating income vs the same period a year earlier. Only from a positive base. |
| Operating income CAGR, 3y | 100.3% | Compound annual growth of operating income over 3 fiscal years: (end / start)^(1/3) - 1. Only when both values are positive. |
| EBITDA growth, 1y | 8.1% | EBITDA vs the same period a year earlier. Only from a positive base. |
| EBITDA CAGR, 3y | 83.1% | Compound annual growth of ebitda over 3 fiscal years: (end / start)^(1/3) - 1. Only when both values are positive. |
| Net income growth, 1y | -2.2% | Net income vs the same period a year earlier. Only from a positive base. |
| Net income CAGR, 3y | 1.5% | Compound annual growth of net income over 3 fiscal years: (end / start)^(1/3) - 1. Only when both values are positive. |
| EPS growth, 1y | 1.3% | EPS vs the same period a year earlier. Only from a positive base. |
| EPS CAGR, 3y | 18.6% | Compound annual growth of eps over 3 fiscal years: (end / start)^(1/3) - 1. Only when both values are positive. |
| Operating cash flow growth, 1y | 41.3% | Operating cash flow vs the same period a year earlier. Only from a positive base. |
| Operating cash flow CAGR, 3y | 51.9% | Compound annual growth of operating cash flow over 3 fiscal years: (end / start)^(1/3) - 1. Only when both values are positive. |
| Free cash flow growth, 1y | 46.1% | Free cash flow vs the same period a year earlier. Only from a positive base. |
| Free cash flow CAGR, 3y | 53.2% | Compound annual growth of free cash flow over 3 fiscal years: (end / start)^(1/3) - 1. Only when both values are positive. |
| Book value growth, 1y | -18.6% | Book value vs the same period a year earlier. Only from a positive base. |
| Total assets growth, 1y | -10.4% | Total assets vs the same period a year earlier. Only from a positive base. |
| Total assets CAGR, 3y | 0.2% | Compound annual growth of total assets over 3 fiscal years: (end / start)^(1/3) - 1. Only when both values are positive. |
| Share count change, 1y | -3.3% | Change in diluted weighted shares vs a year earlier. Negative means buybacks shrank the share count; positive means dilution. |
| Share count change per year, 3y | 40.2% | Change in diluted weighted shares, per year over 3 years. Negative means buybacks shrank the share count; positive means dilution. |
Balance sheet health
| Metric | Value | How it is calculated |
|---|---|---|
| Current ratio | 2.28x | Current assets / current liabilities. |
| Quick ratio | 1.97x | (Cash + short-term investments + receivables) / current liabilities. |
| Cash ratio | 0.91x | (Cash + short-term investments) / current liabilities. |
| Liabilities / assets | 28.1% | Total liabilities / total assets. |
| Working capital | $1.19B | Current assets - current liabilities. |
| Goodwill and intangibles / assets | 13.6% | (Goodwill + intangible assets) / total assets. |
| Tangible book value | $1.84B | Shareholders' equity - goodwill - intangible assets. |
Efficiency
| Metric | Value | How it is calculated |
|---|---|---|
| Asset turnover | 1.14x | Revenue / average total assets. |
| Fixed asset turnover | 18.3x | Revenue / average property, plant and equipment. |
| Receivables turnover | 4.08x | Revenue / average receivables. |
| Days sales outstanding | 89 days | 365 x average receivables / revenue. |
| Days payables | 21 days | 365 x average accounts payable / cost of revenue. |
| FCF conversion | 245.0% | Free cash flow / net income, when net income is positive. |
| Capex / operating cash flow | 4.5% | Capital expenditures / cash from operations, when that is positive. |
Per share
| Metric | Value | How it is calculated |
|---|---|---|
| EPS, diluted | $1.93 | Net income per diluted share, as reported (split-adjusted). Over the last twelve months: the four quarters summed, or net income / latest diluted shares when a quarter has no reported EPS. |
| Revenue per share | $16.04 | Revenue / diluted weighted shares. |
| FCF per share | $4.72 | Free cash flow / diluted weighted shares. |
| Operating cash flow per share | $4.95 | Cash from operations / diluted weighted shares. |
| Book value per share | $9.96 | Shareholders' equity / shares outstanding (diluted weighted shares when not reported). |
| Tangible book per share | $7.91 | Tangible book value / shares outstanding. |
| Cash per share | $3.65 | (Cash + short-term investments) / shares outstanding. |
| Buybacks / FCF | 158.1% | Share buybacks / free cash flow, when free cash flow is positive. |
Valuation
| Metric | Value | How it is calculated |
|---|---|---|
| Market cap | $10.00B | Share price x shares outstanding. |
| Enterprise value | $9.15B | Market cap + total debt - cash - short-term investments. |
| P/E | 20.8x | Market cap / net income. Only when net income is positive. |
| P/S | 2.50x | Market cap / revenue. |
| P/B | 4.31x | Market cap / shareholders' equity. Only when equity is positive. |
| Price / tangible book | 5.42x | Market cap / tangible book value, when positive. |
| P/FCF | 8.50x | Market cap / free cash flow. Only when free cash flow is positive. |
| P/OCF | 8.12x | Market cap / cash from operations, when positive. |
| EV/Sales | 2.29x | Enterprise value / revenue. |
| EV/EBIT | 15.5x | Enterprise value / operating income, when both are positive. |
| EV/EBITDA | 13.0x | Enterprise value / EBITDA, when both are positive. |
| EV/FCF | 7.78x | Enterprise value / free cash flow, when both are positive. |
| FCF yield | 11.8% | Free cash flow / market cap. |
| Earnings yield | 4.8% | Net income / market cap (the inverse of P/E). |
| Shareholder yield | 18.6% | (Dividends paid + share buybacks) / market cap. |
| PEG | 1.12x | P/E / EPS growth per year over 3 years (in percent). Only when both are positive. |
What was Maplebear Inc.'s revenue in fiscal 2025?
Maplebear Inc. reported revenue of $3.74B for fiscal 2025, 10.8% higher than the year before.
Was Maplebear Inc. profitable in fiscal 2025?
Yes. Net income was $447.0M, a net margin of 11.9%.
How much free cash flow did Maplebear Inc. generate in fiscal 2025?
Cash from operations of $971.0M minus capital expenditures of $61.0M left free cash flow of $910.0M.